Wenyi Gu

9.8k total citations · 1 hit paper
155 papers, 5.8k citations indexed

About

Wenyi Gu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wenyi Gu has authored 155 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 37 papers in Oncology and 29 papers in Immunology. Recurrent topics in Wenyi Gu's work include RNA Interference and Gene Delivery (28 papers), Cancer Cells and Metastasis (13 papers) and Immunotherapy and Immune Responses (13 papers). Wenyi Gu is often cited by papers focused on RNA Interference and Gene Delivery (28 papers), Cancer Cells and Metastasis (13 papers) and Immunotherapy and Immune Responses (13 papers). Wenyi Gu collaborates with scholars based in Australia, China and United States. Wenyi Gu's co-authors include Zhi Ping Xu, Weiyu Chen, Chengzhong Yu, Li Li, Jiezhong Chen, Yilun Wu, Meihua Yu, Michael J. Monteiro, Juying Lei and Jinlong Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Wenyi Gu

149 papers receiving 5.7k citations

Hit Papers

Recent advances in MOF-derived carbon-based nanomaterials... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyi Gu Australia 41 1.9k 1.5k 1.2k 900 806 155 5.8k
Xiaozhou Mou China 38 1.9k 1.0× 1.4k 1.0× 2.5k 2.0× 667 0.7× 974 1.2× 185 5.8k
Huijun Zhu China 34 1.7k 0.9× 920 0.6× 347 0.3× 665 0.7× 533 0.7× 135 4.5k
Jie Li China 47 1.8k 0.9× 2.2k 1.4× 3.6k 3.0× 560 0.6× 1.1k 1.4× 171 6.7k
Ki Taek Nam South Korea 43 1.8k 1.0× 658 0.4× 1.2k 1.0× 676 0.8× 805 1.0× 158 5.7k
Lei Ren China 48 2.1k 1.1× 2.2k 1.4× 3.8k 3.2× 473 0.5× 1.7k 2.2× 221 7.9k
Jiang Xia Hong Kong 42 4.3k 2.2× 786 0.5× 1.2k 1.0× 377 0.4× 595 0.7× 167 7.1k
Yannan Yang Australia 41 1.7k 0.9× 2.5k 1.6× 2.6k 2.2× 289 0.3× 1.3k 1.6× 121 6.3k
Ping Hu China 43 2.8k 1.5× 1.5k 1.0× 1.9k 1.6× 344 0.4× 526 0.7× 137 6.2k
Yanhong Duo China 27 1.3k 0.7× 1.3k 0.9× 1.8k 1.5× 245 0.3× 468 0.6× 42 4.1k
Yu Zhao China 43 2.8k 1.5× 1.1k 0.8× 1.5k 1.2× 437 0.5× 781 1.0× 172 6.1k

Countries citing papers authored by Wenyi Gu

Since Specialization
Citations

This map shows the geographic impact of Wenyi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Gu more than expected).

Fields of papers citing papers by Wenyi Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Gu. The network helps show where Wenyi Gu may publish in the future.

Co-authorship network of co-authors of Wenyi Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Gu. A scholar is included among the top collaborators of Wenyi Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Gu. Wenyi Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qing, Xingxing Gao, Fangling Li, et al.. (2025). Macrophage‐Mediated Delivery of miR‐34a‐5p‐Nanoparticles for Pathogenic Inhibition of Kaposi's Sarcoma‐Associated Herpesvirus. Journal of Medical Virology. 97(3). e70298–e70298.
2.
Gu, Wenyi, Jiajing Zhao, & Yu Xu. (2025). Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge. Frontiers in Immunology. 16. 1512093–1512093. 5 indexed citations
3.
Li, Z., Hongzhi Chen, Wenping Cai, et al.. (2024). Effects of Seipin on Mouse Mesenchymal Stem Cell Osteo-Adipogenic Balance. Stem Cells and Development. 33(7-8). 177–188.
4.
Fu, Fanfan, et al.. (2024). Polymeric silk fibroin hydrogel as a conductive and multifunctional adhesive for durable skin and epidermal electronics. SHILAP Revista de lepidopterología. 3(3). e20240027–e20240027. 3 indexed citations
5.
Xu, Lei, Xiaopan Liu, Simin Wei, et al.. (2023). Chitosan-coated artesunate protects against ulcerative colitis via STAT6-mediated macrophage M2 polarization and intestinal barrier protection. International Journal of Biological Macromolecules. 254(Pt 1). 127680–127680. 25 indexed citations
6.
Wang, Yubing, Yufei Feng, Hao Peng, et al.. (2023). Bioinformatics-Based Identification of CircRNA-MicroRNA-mRNA Network for Calcific Aortic Valve Disease. Genetics Research. 2023. 1–12. 1 indexed citations
7.
Li, Ying, Xiaohua Tan, Qinghua Cui, et al.. (2023). Parthenolide inhibits proliferation of cells infected with Kaposi’s sarcoma-associated herpesvirus by suppression of the NF-κB signaling pathway. Archives of Virology. 168(2). 39–39. 3 indexed citations
8.
Bobrin, Valentin A., et al.. (2022). RGD-Coated Polymer Nanoworms for Enriching Cancer Stem Cells. Cancers. 15(1). 234–234. 8 indexed citations
9.
Zhang, Jinli, et al.. (2022). miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos. PeerJ. 10. e13233–e13233. 13 indexed citations
10.
Huang, Xiaoyue, Wenyi Gu, Songchang Hu, et al.. (2020). Phosphorus-doped inverse opal g-C3N4 for efficient and selective CO generation from photocatalytic reduction of CO2. Catalysis Science & Technology. 10(11). 3694–3700. 44 indexed citations
11.
Kapeleris, Joanna, Hong Zou, Qi Yan, et al.. (2019). Cancer stemness contributes to cluster formation of colon cancer cells and high metastatic potentials. Clinical and Experimental Pharmacology and Physiology. 47(5). 838–847. 26 indexed citations
13.
Li, Li, Run Zhang, Wenyi Gu, & Zhi Ping Xu. (2017). Mannose-conjugated layered double hydroxide nanocomposite for targeted siRNA delivery to enhance cancer therapy. Nanomedicine Nanotechnology Biology and Medicine. 14(7). 2355–2364. 60 indexed citations
14.
Li, Li, Zi Gu, Wenyi Gu, & Zhi Ping Xu. (2016). Direct synthesis of layered double hydroxide nanosheets for efficient siRNA delivery. RSC Advances. 6(98). 95518–95526. 27 indexed citations
15.
Gu, Wenyi, et al.. (2016). Effect of Li+/H+ exchange in water treated Ta-doped Li7La3Zr2O12. Solid State Ionics. 292. 122–129. 107 indexed citations
17.
Gu, Wenyi, et al.. (2013). HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation. Placenta. 34(11). 1044–1052. 34 indexed citations
18.
Gu, Wenyi, Chengtie Wu, Jiezhong Chen, & Yin Xiao. (2013). Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. QUT ePrints (Queensland University of Technology). 2 indexed citations
20.
Gu, Wenyi, Lisa N Putral, Kylie Hengst, et al.. (2006). Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Therapy. 13(11). 1023–1032. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026